Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer

Background Personalized immunotherapy of pancreatic ductal adenocarcinoma (PDAC) through T-cell mediated targeting of tumor-specific, mutanome-encoded neoepitopes may offer new opportunities to combat this disease, in particular by countering recurrence after primary tumor resection. However, the se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Volkmar, Michael (VerfasserIn) , Hoser, Dana (VerfasserIn) , Lauenstein, Claudia (VerfasserIn) , Rebmann, Janina (VerfasserIn) , Hotz-Wagenblatt, Agnes (VerfasserIn) , Rieger, Jan (VerfasserIn) , Poschke, Isabel (VerfasserIn) , Becker, Jonas P. (VerfasserIn) , Riemer, Angelika (VerfasserIn) , Sprick, Martin (VerfasserIn) , Trumpp, Andreas (VerfasserIn) , Strobel, Oliver (VerfasserIn) , Blankenstein, Thomas (VerfasserIn) , Willimsky, Gerald (VerfasserIn) , Offringa, Rienk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 3 June 2025
In: Journal for ImmunoTherapy of Cancer
Year: 2025, Jahrgang: 13, Heft: 6, Pages: 1-15
ISSN:2051-1426
DOI:10.1136/jitc-2025-011802
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1136/jitc-2025-011802
Verlag, kostenfrei, Volltext: https://jitc.bmj.com/content/13/6/e011802
Volltext
Verfasserangaben:Michael Volkmar, Dana Hoser, Claudia Lauenstein, Janina Rebmann, Agnes Hotz-Wagenblatt, Jan Rieger, Isabel Poschke, Jonas P. Becker, Angelika B. Riemer, Martin Sprick, Andreas Trumpp, Oliver Strobel, Thomas Blankenstein, Gerald Willimsky, Rienk Offringa

MARC

LEADER 00000naa a2200000 c 4500
001 1939334691
003 DE-627
005 20251023112654.0
007 cr uuu---uuuuu
008 251023s2025 xx |||||o 00| ||eng c
024 7 |a 10.1136/jitc-2025-011802  |2 doi 
035 |a (DE-627)1939334691 
035 |a (DE-599)KXP1939334691 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Volkmar, Michael  |d 1976-  |e VerfasserIn  |0 (DE-588)143064592  |0 (DE-627)704379457  |0 (DE-576)334850193  |4 aut 
245 1 0 |a Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer  |c Michael Volkmar, Dana Hoser, Claudia Lauenstein, Janina Rebmann, Agnes Hotz-Wagenblatt, Jan Rieger, Isabel Poschke, Jonas P. Becker, Angelika B. Riemer, Martin Sprick, Andreas Trumpp, Oliver Strobel, Thomas Blankenstein, Gerald Willimsky, Rienk Offringa 
264 1 |c 3 June 2025 
300 |b Illustrationen, Diagramme 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 23.10.2025 
520 |a Background Personalized immunotherapy of pancreatic ductal adenocarcinoma (PDAC) through T-cell mediated targeting of tumor-specific, mutanome-encoded neoepitopes may offer new opportunities to combat this disease, in particular by countering recurrence after primary tumor resection. However, the sensitive and accurate calling of somatic mutations in PDAC tissue samples is compromised by the low tumor cell content. Moreover, the repertoire of immunogenic neoepitopes in PDAC is limited due to the low mutational load of the majority of these tumors.Methods We developed a workflow involving the combined analysis of next-generation DNA and RNA sequencing data from matched pairs of primary tumor samples and patient-derived xenograft models towards the enhanced detection of driver mutations as well as single nucleotide variants encoding potentially immunogenic T-cell neoepitopes. Subsequently, we immunized HLA/human T-cell receptor (TCR) locus-transgenic mice with synthetic peptides representing candidate neoepitopes, and molecularly cloned the genes encoding TCRs targeting these epitopes.Result Application of our pipeline resulted in the identification of greater numbers of non-synonymous mutations encoding candidate neoepitopes with increased confidence. Furthermore, we provide proof of concept for the successful isolation of HLA-restricted TCRs from humanized mice immunized with different neoepitopes, several of which would not have been selected based on mutanome analysis of PDAC tissue samples alone. These TCRs mediate specific T-cell reactivity against the tumor cells in which the corresponding mutations were identified.Conclusion Enhanced mutanome analysis and candidate neoepitope selection increase the likelihood of identifying therapeutically relevant neoepitopes, and thereby support the optimization of personalized immunotherapy for PDAC and other poorly immunogenic cancers. 
700 1 |a Hoser, Dana  |e VerfasserIn  |4 aut 
700 1 |a Lauenstein, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Rebmann, Janina  |e VerfasserIn  |4 aut 
700 1 |a Hotz-Wagenblatt, Agnes  |e VerfasserIn  |0 (DE-588)1163289310  |0 (DE-627)1027495982  |0 (DE-576)507876806  |4 aut 
700 1 |a Rieger, Jan  |e VerfasserIn  |4 aut 
700 1 |a Poschke, Isabel  |e VerfasserIn  |0 (DE-588)1143622111  |0 (DE-627)1002893240  |0 (DE-576)495086711  |4 aut 
700 1 |a Becker, Jonas P.  |e VerfasserIn  |4 aut 
700 1 |a Riemer, Angelika  |e VerfasserIn  |0 (DE-588)1167191420  |0 (DE-627)1030878013  |0 (DE-576)511025688  |4 aut 
700 1 |a Sprick, Martin  |e VerfasserIn  |0 (DE-588)1183116942  |0 (DE-627)1663038716  |4 aut 
700 1 |a Trumpp, Andreas  |d 1964-  |e VerfasserIn  |0 (DE-588)1081774134  |0 (DE-627)846650266  |0 (DE-576)454773552  |4 aut 
700 1 |a Strobel, Oliver  |d 1974-  |e VerfasserIn  |0 (DE-588)123658977  |0 (DE-627)706385101  |0 (DE-576)293812357  |4 aut 
700 1 |a Blankenstein, Thomas  |e VerfasserIn  |4 aut 
700 1 |a Willimsky, Gerald  |e VerfasserIn  |4 aut 
700 1 |a Offringa, Rienk  |e VerfasserIn  |0 (DE-588)1066807485  |0 (DE-627)817963391  |0 (DE-576)426161424  |4 aut 
773 0 8 |i Enthalten in  |t Journal for ImmunoTherapy of Cancer  |d London : BioMed Central, 2013  |g 13(2025), 6, Artikel-ID e011802, Seite 1-15  |h Online-Ressource  |w (DE-627)750086335  |w (DE-600)2719863-7  |w (DE-576)383767369  |x 2051-1426  |7 nnas  |a Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer 
773 1 8 |g volume:13  |g year:2025  |g number:6  |g elocationid:e011802  |g pages:1-15  |g extent:15  |a Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer 
856 4 0 |u https://doi.org/10.1136/jitc-2025-011802  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://jitc.bmj.com/content/13/6/e011802  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20251023 
993 |a Article 
994 |a 2025 
998 |g 1066807485  |a Offringa, Rienk  |m 1066807485:Offringa, Rienk  |d 910000  |d 910200  |e 910000PO1066807485  |e 910200PO1066807485  |k 0/910000/  |k 1/910000/910200/  |p 15  |y j 
998 |g 123658977  |a Strobel, Oliver  |m 123658977:Strobel, Oliver  |d 50000  |e 50000PS123658977  |k 0/50000/  |p 12 
998 |g 1081774134  |a Trumpp, Andreas  |m 1081774134:Trumpp, Andreas  |d 140000  |e 140000PT1081774134  |k 0/140000/  |p 11 
998 |g 1183116942  |a Sprick, Martin  |m 1183116942:Sprick, Martin  |d 50000  |e 50000PS1183116942  |k 0/50000/  |p 10 
998 |g 1167191420  |a Riemer, Angelika  |m 1167191420:Riemer, Angelika  |d 50000  |e 50000PR1167191420  |k 0/50000/  |p 9 
998 |g 1143622111  |a Poschke, Isabel  |m 1143622111:Poschke, Isabel  |d 50000  |e 50000PP1143622111  |k 0/50000/  |p 7 
998 |g 1163289310  |a Hotz-Wagenblatt, Agnes  |m 1163289310:Hotz-Wagenblatt, Agnes  |d 140000  |e 140000PH1163289310  |k 0/140000/  |p 5 
998 |g 143064592  |a Volkmar, Michael  |m 143064592:Volkmar, Michael  |d 50000  |e 50000PV143064592  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1939334691  |e 4790939596 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1939334691","physDesc":[{"noteIll":"Illustrationen, Diagramme","extent":"15 S."}],"title":[{"title":"Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer","title_sort":"Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancer"}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 23.10.2025"],"origin":[{"dateIssuedDisp":"3 June 2025","dateIssuedKey":"2025"}],"person":[{"given":"Michael","role":"aut","family":"Volkmar","display":"Volkmar, Michael"},{"family":"Hoser","given":"Dana","role":"aut","display":"Hoser, Dana"},{"family":"Lauenstein","role":"aut","given":"Claudia","display":"Lauenstein, Claudia"},{"display":"Rebmann, Janina","given":"Janina","role":"aut","family":"Rebmann"},{"display":"Hotz-Wagenblatt, Agnes","given":"Agnes","role":"aut","family":"Hotz-Wagenblatt"},{"display":"Rieger, Jan","family":"Rieger","role":"aut","given":"Jan"},{"family":"Poschke","given":"Isabel","role":"aut","display":"Poschke, Isabel"},{"family":"Becker","given":"Jonas P.","role":"aut","display":"Becker, Jonas P."},{"family":"Riemer","role":"aut","given":"Angelika","display":"Riemer, Angelika"},{"display":"Sprick, Martin","given":"Martin","role":"aut","family":"Sprick"},{"display":"Trumpp, Andreas","role":"aut","given":"Andreas","family":"Trumpp"},{"family":"Strobel","given":"Oliver","role":"aut","display":"Strobel, Oliver"},{"role":"aut","given":"Thomas","family":"Blankenstein","display":"Blankenstein, Thomas"},{"role":"aut","given":"Gerald","family":"Willimsky","display":"Willimsky, Gerald"},{"display":"Offringa, Rienk","family":"Offringa","role":"aut","given":"Rienk"}],"relHost":[{"disp":"Enhanced mutanome analysis towards the induction of neoepitope-reactive T-cell responses for personalized immunotherapy of pancreatic cancerJournal for ImmunoTherapy of Cancer","recId":"750086335","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal for ImmunoTherapy of Cancer","title_sort":"Journal for ImmunoTherapy of Cancer","subtitle":"official journal of the Society for Immunotherapy of Cancer (SITC)"}],"part":{"pages":"1-15","issue":"6","text":"13(2025), 6, Artikel-ID e011802, Seite 1-15","extent":"15","year":"2025","volume":"13"},"id":{"issn":["2051-1426"],"eki":["750086335"],"zdb":["2719863-7"]},"note":["Gesehen am 29.06.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"pubHistory":["1.2013 -"],"origin":[{"publisherPlace":"London","dateIssuedKey":"2013","dateIssuedDisp":"2013-","publisher":"BioMed Central"}]}],"id":{"eki":["1939334691"],"doi":["10.1136/jitc-2025-011802"]},"name":{"displayForm":["Michael Volkmar, Dana Hoser, Claudia Lauenstein, Janina Rebmann, Agnes Hotz-Wagenblatt, Jan Rieger, Isabel Poschke, Jonas P. Becker, Angelika B. Riemer, Martin Sprick, Andreas Trumpp, Oliver Strobel, Thomas Blankenstein, Gerald Willimsky, Rienk Offringa"]}} 
SRT |a VOLKMARMICENHANCEDMU3202